跳至主要内容
临床试验/NCT06205966
NCT06205966招募中不适用

A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children

Milosevits Gergely2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2023年12月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
142
试验地点
2
主要终点
Time to healing, defined as number of hours until absence of symptoms (fever, runny nose, stuffy nose, sneezing, sore throat, cough, feeling tired) as well as absence of use of Non-steroidal anti-inflammatory drugs (NSAIDs)

研究概览

简要总结

This study investigates the effect of Lactobacillus reuteri probiotic strains (ATCC PTA 5289 and DSM 17938) on symptoms of viral upper-respiratory tract infections in children.

详细描述

Lactobacillus reuteri probiotic strains (ATCC PTA 5289 and DSM 17938) have been shown to significantly reduce the number of febrile days and pain severity in upper respiratory tract infections in children aged six months to 5 years. The investigator's planned study complements this earlier publication by significantly increasing the number of cases and expanding the age range studied including children from 4 to 17 years of age diagnosed with viral upper respiratory-tract infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children with symptoms of upper respiratory tract infection (coughing/fever/sneezing/runny or congested nose/pharynx pain)
  • Any gender
  • Age from 4 years to 17 years
  • Signing a informed consent form by at least one parent, foster parent or guardian after patient information and by children aged over 6 years
  • Negative Strep test

排除标准

  • Use of antibiotics or probiotics in the 10 days prior to study enrolment
  • Use of a probiotic other than the test sample during the study
  • Eight or more otitis media within 12 months
  • Two or more bacterial sinusitis within 12 months
  • Two or more pneumonia episodes within 12 months
  • History of two or more invasive infections (meningitis, cellulitis, osteomyelitis, septicaemia)
  • Chronic diarrhea
  • Recurrent deep skin or organ abscesses
  • Persistent superficial candidiasis
  • Use of antibiotics for two months or more to treat respiratory infections within 12 months
  • Gastroesophageal reflux
  • Perennial (e.g., dust mite or mold) or current seasonal hay fever allergy
  • Primary or secondary ciliary dyskinesia
  • Congenital malformations of the respiratory tract

结局指标

主要结局

Time to healing, defined as number of hours until absence of symptoms (fever, runny nose, stuffy nose, sneezing, sore throat, cough, feeling tired) as well as absence of use of Non-steroidal anti-inflammatory drugs (NSAIDs)

时间窗: 10 days

次要结局

  • Number of children receiving antibiotic treatment in each treatment group.(10 days)
  • Days of absences from day care center/school.(10 days)
  • Duration of symptoms (runny nose, stuffy nose, sneezing, sore throat, cough, feeling tired)(10 days)
  • Severity of symptoms (runny nose, stuffy nose, sneezing, sore throat, cough, feeling tired) recorded in a "Symptom Diary".(10 days)
  • Duration of fever, defined as the total number of hours that the child has a core temperature >38oC measured twice per day.(10 days)
  • Amount of NSAIDs used.(10 days)
  • Total amount of days of antibiotic use during the study, reported during the whole duration of the study in a the "Symptom Diary".(10 days)
  • Number of unplanned medical visits (other than "Visit 1 and 2").(10 days)

研究者

发起方
Milosevits Gergely
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Milosevits Gergely

Principal Investigator

Szent Miklós Szolgálat Kft.

研究点 (2)

Loading locations...

相似试验